What Is This?
In January 2025, a paper published in Nature Medicine by Matthew Campen and colleagues at the University of New Mexico reported something that, if its implications hold, belongs in the same category as asbestos, leaded petrol, and tobacco — a ubiquitous industrial material that we have been confident is safe, that is present in every human body, and that may be causing systematic neurological harm.
The paper analysed brain tissue samples from human cadavers — taken in 2016 and 2024 — alongside liver and kidney samples, using a technique called pyrolysis gas chromatography-mass spectrometry (Py-GC/MS) that can detect microplastics and nanoplastics at extremely low concentrations. The findings:
- Microplastics and nanoplastics (MNPs) were found in 100% of human brain samples examined.
- The brain contained significantly higher concentrations of MNPs than the liver or kidney — the organs traditionally studied as plastic accumulation sites. The brain samples contained approximately 7-30 times higher plastic concentrations than liver samples.
- MNP concentrations in brain samples from 2024 were significantly higher than in samples from 2016 — increasing over an 8-year period as global plastic production has continued to rise. The trend line is upward.
- The brains of individuals who died with dementia diagnoses contained substantially higher MNP concentrations than brains from individuals who died without dementia.
The predominant polymer found in brain tissue was polyethylene — the most produced plastic in the world, found in single-use packaging, bottles, and bags. The concentrations were measurable in micrograms per gram of brain tissue.^1
What are microplastics?
Plastics degrade — not into harmless components, but into progressively smaller fragments. Microplastics are fragments between 1 micrometer and 5 millimetres. Nanoplastics are below 1 micrometer. These particles are now documented in every environmental matrix studied: deep ocean sediments, Arctic ice, rainwater, soil, drinking water, food. The average human is estimated to consume approximately 5 grams of plastic per week — roughly the weight of a credit card — through food, water, and air.^2
Plastics were assumed to be biologically inert. The regulatory approvals of food-contact plastics were based on the premise that the material itself doesn't migrate into food or tissue in biologically significant quantities. This assumption is now under direct empirical pressure.
Why Does It Matter?
- The brain shouldn't contain significant quantities of foreign particles of any kind. The blood-brain barrier evolved precisely to restrict passage of potentially harmful substances from the bloodstream into brain tissue. That microplastics — and specifically nanoplastics small enough to cross the blood-brain barrier — are accumulating in brain tissue at measurable concentrations is not consistent with the "biologically inert" safety characterisation. Something is crossing the barrier. Something is accumulating. Whether it causes harm is the open question, but the premise on which safety was assumed has been falsified.
- The dementia association is the most alarming finding — and the most contested. The study found higher microplastic concentrations in dementia patients' brains than in neurologically healthy controls. This is a cross-sectional observational finding — it does not establish causality. People with dementia may accumulate more MNPs because impaired BBB function allows more plastic through, rather than microplastics causing dementia. Alternatively, both may have a common upstream cause (inflammation, metabolic dysfunction). The correlation is real. The direction of causality is unknown. Distinguishing between these possibilities requires longitudinal studies that have not yet been conducted.^3
- The trend direction over time is independent of the dementia question — and unambiguously concerning. The 2016 vs. 2024 comparison shows that plastic concentrations in brain tissue increased significantly over 8 years. This is not confounded by dementia status or individual variation — it's a time-trend. As plastic production has continued to grow (now approximately 400 million tonnes per year globally), human body burden is increasing. Whether or not current concentrations are causing acute harm, the concentrations will be higher in 10 years than they are today, and we don't know at what concentration threshold (if any) harm begins.
- This is potentially an asbestos moment for the plastics industry. Asbestos was known to be prevalent in human environments for decades before the causal link to mesothelioma and lung cancer was established and acted upon. The delay between exposure evidence and regulation cost hundreds of thousands of lives. The sequence here is similar: universal exposure established, presence in tissues confirmed, plausible biological mechanisms under investigation, health outcomes correlation observed but causality not yet proven. The lesson from asbestos (and from leaded petrol, and from tobacco) is that waiting for definitive causality before reducing exposure can be extremely costly, and that industries with economic interests in continuing production systematically fund delay. PFAS ("forever chemicals") are the most recent example of the same pattern.^4
- The practical implication is that plastic reduction is no longer only an environmental issue. If microplastics accumulate in the brain at concentrations that increase over time and correlate with neurological disease, then personal plastic exposure is a health question, not just an ecological one. The sources with the most evidence for plastic ingestion: bottled water (releases microplastics, especially when heated or shaken), heated plastic food containers, tea bags (some release billions of plastic particles per cup), plastic cutting boards, and canned foods with plastic liners. Filtration approaches: reverse osmosis and some water filters remove most microplastics from drinking water. Air exposure is harder to mitigate — indoor environments often have higher plastic particle concentrations than outdoor air.
Key People & Players
Matthew Campen (University of New Mexico) — Lead author of the 2025 Nature Medicine paper. His lab has been studying environmental toxicant exposure in human tissue samples. The brain MNP study is the most significant of their work to date.^5
Dick Vethaak (Vrije Universiteit Amsterdam) — One of the earliest researchers to document microplastic presence in human blood and tissue, and a consistent voice for taking the health implications seriously before definitive causal evidence is established. His work on MNPs in human blood (2022) was the first major study to demonstrate that MNPs circulate systemically in living humans.
Sherri "Sam" Mason (Pennsylvania State Erie) — Environmental scientist who has been one of the most prominent public researchers on microplastics in drinking water and in human environments. Her work on bottled water contamination is the basis for much of the practical guidance on reducing exposure.
Shanna Swan (Mount Sinai) — Reproductive epidemiologist whose Count Down (2021) documented the dramatic global decline in sperm counts and connected it partly to endocrine-disrupting chemicals including those associated with plastics (phthalates, BPA). Her work is the strongest evidence base for plastic chemical exposure affecting human health at population scale, before the MNPs-in-brain findings.
The plastics industry — The International Council of Chemical Associations and PlasticsEurope have funded research questioning microplastic health risk and have lobbied against precautionary regulation. This is the same pattern documented with tobacco, asbestos, PFAS, and leaded petrol — the same public relations firms, the same "more research needed" framing, the same strategic delay.
The Current State
The science is moving fast and the regulatory response is lagging, as is consistent with historical precedent.
What's established:
- MNPs are present in virtually every human tissue examined, including blood, liver, kidney, brain, placenta, and breast milk
- MNP concentrations in tissue are increasing over time with global plastic production
- MNPs cross the blood-brain barrier and accumulate in brain tissue at higher concentrations than other organs
- Correlation between brain MNP concentration and dementia diagnoses is documented
What's not established:
- Causal relationship between MNP exposure and any specific disease
- The concentration threshold (if any) at which MNP accumulation causes biological harm
- Which specific plastic types or associated chemicals are most responsible for any harm
- Whether the health effects are from the plastic particles themselves, the chemicals that leach from them, or the contaminants (heavy metals, persistent organic pollutants) that plastics absorb and concentrate
The regulatory picture: The EU has moved furthest — banning single-use plastics (straws, cutlery, plates) and requiring member states to reduce single-use packaging by 2030. The US has state-level bans but no comprehensive federal approach. The UN Global Plastics Treaty negotiations, aimed at a binding global agreement to reduce plastic production and pollution, were still ongoing as of early 2026.
The precautionary logic: Given the asbestos precedent and the pattern of industry-funded delay, the question for individuals and policymakers is not whether to wait for definitive causal evidence but how to weigh exposure reduction now against the cost of precaution. The exposure reduction options that are most effective (reverse osmosis water filtration, reduced bottled water use, avoiding heating food in plastic containers) have low individual cost and plausible large individual benefit if the hypothesis holds. The precautionary logic favours adoption before definitive causal evidence is in.
Best Resources to Learn More
- Nature Medicine: Bioaccumulation of microplastics in decedent human brains (2025) — The primary study. The abstract is freely available; the methods section is important for understanding what was actually measured.^6
- Count Down by Shanna Swan — The broader case for plastic-associated chemical harm to human reproductive health. The strongest evidence base pre-2025 study.^7
- The New Lede: "Microplastics found in human brains in high levels" — The best non-specialist news coverage of the 2025 study.^8
- Nature Medicine commentary: "Challenges in studying microplastics in human brain" — The scientific community's response — what's established, what's contested, and what research is needed.^9
- Plastic: A Toxic Love Story by Susan Freinkel — The history of plastic's adoption and the gradual accumulation of evidence about its biological effects. Essential context.^10